UNCLASSIFIED THERAPEUTIC AGENTS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
LEVODOPA & CARBIDOPA & ENTACAPONE: products 1 to 5 of 5.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Stalevo 100 & 25 & 200mg TabDIN 02305941 | Limited Use, codes 367 | $1.7471per source unit | Requirements & sourcesBuild cost plan |
| Stalevo 125 & 31.25 & 200mg TabDIN 02337835 | Limited Use, codes 367 | $1.7471per source unit | Requirements & sourcesBuild cost plan |
| Stalevo 150 & 37.5 & 200mg TabDIN 02305968 | Limited Use, codes 367 | $1.7471per source unit | Requirements & sourcesBuild cost plan |
| Stalevo 50 & 12.5 & 200mg TabDIN 02305933 | Limited Use, codes 367 | $1.7471per source unit | Requirements & sourcesBuild cost plan |
| Stalevo 75 & 18.75 & 200mg TabDIN 02337827 | Limited Use, codes 367 | $1.7471per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
92:00 UNCLASSIFIED THERAPEUTIC AGENTS.
92:20 Biologic Response Modifiers.
92:36 Disease-Modifying Antirheumatic Agents.
92:44 Immunosuppressive Agents.
92:92 Other Miscellaneous Therapeutic Agents.